Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Solid Biosciences LLC
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It develops SGT-212 for the treatment of Friedreich's ataxia that is in phase 1b clinical trial; SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia that is in preclinical phase; SGT-601 the trea… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: January 26, 2018
Headquarters: 500 Rutherford Avenue, Charlestown, MA, United States, 02129
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$7.41
Near-term / short-term trend
Weekly
40-Week SMA
$6.16
Medium-term trend
Weekly
80-Week SMA
$5.31
Cyclical trend (business cycle)
Weekly
200-Week SMA
$6.18
Secular trend (multi-year)
Monthly
10-Month SMA
$6.19
Near-term monthly trend
Monthly
20-Month SMA
$5.39
Medium-term monthly trend
Monthly
40-Month SMA
$5.83
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$4.90
support
1.06x
9 months ago
$3.30
support
1.42x
10 months ago
$3.10
support
6.04x
14 months ago
Historical Earnings Reactions (34 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-3.63%
0.00%
35.29%
8.56%
-70.91%
1 Day
-2.64%
-0.24%
50.00%
35.29%
-74.36%
1 Week
-2.05%
-2.29%
41.18%
41.09%
-66.55%
2 Weeks
-3.35%
-2.78%
39.39%
37.47%
-63.18%
1 Month
1.47%
-0.32%
48.48%
106.53%
-62.64%
Next earnings: May 21, 2026
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
-3.5%
37.5%
8
Feb
2.8%
44.4%
9
Mar
-10.1%
33.3%
9
Apr
-1.6%
33.3%
9
May
4.0%
50.0%
8
Jun
9.7%
50.0%
8
Jul
8.5%
50.0%
8
Aug
-0.8%
37.5%
8
Sep
-6.9%
37.5%
8
Oct
-4.1%
25.0%
8
Nov
-5.6%
62.5%
8
Dec
25.0%
50.0%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.42%
41.2%
393
Tuesday
0.10%
47.2%
430
Wednesday
0.16%
44.8%
426
Thursday
-0.14%
44.6%
419
Friday
0.62%
44.6%
419
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 101.7%
Insider Transactions — Smart Summary
Total insider ownership: 0.8%
Founder-led management: Annie Ganot (Co-Founder & VP of Patient Advocacy)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Solid Biosciences LLC
(SLDB) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.